Notch signaling drives intestinal graft-versus-host disease in mice and nonhuman primates
Science Translational Medicine · 28.06.2023 · 15 (702)
DOI: 10.1126/scitranslmed.add1175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 28.06.2023. Verfasst von Victor Tkachev und 30 weiteren Autor:innen. Beteiligte Einrichtung: Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Notch signaling promotes T cell pathogenicity and graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (allo-HCT) in mice, with a dominant role for the Delta-like Notch ligand DLL4. To assess whether Notch’s effects are evolutionarily conserved and to identify the mechanisms of Notch signaling inhibition, we studied antibody-mediated DLL4 blockade in a nonhuman primate (NHP) model similar to human allo-HCT. Short-term DLL4 blockade improved posttransplant survival with durable protection from gastrointestinal GVHD in particular. Unlike prior immunosuppressive strategies tested in the NHP GVHD model, anti-DLL4 interfered with a T cell transcriptional program associated with intestinal infiltration. In cross-species investigations, Notch inhibition decreased surface abundance of the gut-homing integrin α4β7 in conventional T cells while preserving α4β7 in regulatory T cells, with findings suggesting increased β1 competition for α4 binding in conventional T cells. Secondary lymphoid organ fibroblastic reticular cells emerged as the critical cellular source of Delta-like Notch ligands for Notch-mediated up-regulation of α4β7 integrin in T cells after allo-HCT. Together, DLL4-Notch blockade decreased effector T cell infiltration into the gut, with increased regulatory to conventional T cell ratios early after allo-HCT. Our results identify a conserved, biologically unique, and targetable role of DLL4-Notch signaling in intestinal GVHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA 02114, USA.
- Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
- Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
- Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
- Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Immunology Graduate Group and Veterinary Medical Scientist Training Program, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Victor Tkachev, Ashley Vanderbeck, Eric Perkey, Scott N Furlan, Connor McGuckin, Daniela Gómez Atria, Ulrike Gerdemann, Jennifer Lane, Daniel J Hunt, Hengqi Zheng, Lucrezia Colonna, Michelle Hoffman, Riley Outen, Samantha Kelly, Anneka Allman, Ute Koch, Freddy Radtke, Burkhard Ludewig, Brandon Burbach, Yoji Shimizu, Angela Panoskaltsis-Mortari, Stephen M Carpenter, Olivier Harari, Frank Kuhnert, Gavin Thurston, Bruce R Blazar, Leslie S Kean, Ivan Maillard
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Tkachev, V., Vanderbeck, A., Perkey, E., Furlan, S. N., McGuckin, C., Gómez Atria, D., Gerdemann, U., Rui, X., Lane, J., Hunt, D. J., Zheng, H., Colonna, L., Hoffman, M., Yu, A., Outen, R., Kelly, S., Allman, A., Koch, U., Radtke, F., …, & Maillard, I. (2023). Notch signaling drives intestinal graft-versus-host disease in mice and nonhuman primates. Science Translational Medicine, 15(702). https://doi.org/10.1126/scitranslmed.add1175
Vancouver
Tkachev V, Vanderbeck A, Perkey E, Furlan SN, McGuckin C, Gómez Atria D, et al. Notch signaling drives intestinal graft-versus-host disease in mice and nonhuman primates. Science Translational Medicine. 2023;15(702). doi:10.1126/scitranslmed.add1175
BibTeX
@article{Tkachev2023,
author = {Tkachev, Victor and Vanderbeck, Ashley and Perkey, Eric and Furlan, Scott N and McGuckin, Connor and Gómez Atria, Daniela and Gerdemann, Ulrike and Rui, Xianliang and Lane, Jennifer and Hunt, Daniel J and Zheng, Hengqi and Colonna, Lucrezia and Hoffman, Michelle and Yu, Alison and Outen, Riley and Kelly, Samantha and Allman, Anneka and Koch, Ute and Radtke, Freddy and Ludewig, Burkhard and Burbach, Brandon and Shimizu, Yoji and Panoskaltsis-Mortari, Angela and Chen, Guoying and Carpenter, Stephen M and Harari, Olivier and Kuhnert, Frank and Thurston, Gavin and Blazar, Bruce R and Kean, Leslie S and Maillard, Ivan},
title = {Notch signaling drives intestinal graft-versus-host disease in mice and nonhuman primates},
journal = {Science Translational Medicine},
year = {2023},
volume = {15},
number = {702},
doi = {10.1126/scitranslmed.add1175}
}
EUVIMED